Introduction
The brain needs nutrients to function, one of which is folate (vitamin B9). You might be familiar with its artificial form, folic acid, which is recommended for pregnant people to take to support the baby’s brain development.1 But folate is important at all ages, as it helps brain cells to communicate with each other and repair themselves.2 When the brain does not get enough folate, cerebral folate deficiency (CFD) can develop, leading to brain changes that can be detected using magnetic resonance imaging (MRI).
In this article, we will give a brief overview of CFD, explain how MRI works, and explore what an MRI can reveal about brain changes in CFD patients.
Overview of cerebral folate deficiency (CFD)
Cerebral folate deficiency (CFD) is a disorder associated with low levels of folate in the brain, despite having appropriate levels of folate in the blood.3 Usually, this stems from issues with a protein called folate receptor alpha (FRα), which is supposed to shuttle folate from the bloodstream into the brain.4
Symptoms of CFD
CFD is most common in infants, with symptoms typically starting to emerge around four months and becoming more pronounced by 30 months.4 Symptoms include:4
- Agitation
- Sleep problems
- Decreased head growth rate
- Neurodevelopmental delay or regression – late development or loss of skills such as walking or talking
- Ataxia - poor muscle control
- Hypotonia - poor muscle tone, resulting in weak limbs
- Seizures
- Lower limb pyramidal signs – such as the Babinski sign (considered normal in children under two, but may indicate CFD if it persists)
- Vision or hearing loss (usually in children with CFD aged three or older)3
The good news is that CFD in infants is treatable,1 which is why getting an early diagnosis is so crucial. Clinicians use several tools to aid the diagnosis process, including MRI scans.
Magnetic resonance imaging (MRI)
What is MRI?
MRI or magnetic resonance imaging is a non-invasive scanning technique that generates pictures (MRI images) that doctors can interpret. MRIs are often used to examine the brain because the resulting images have a high level of detail without harmful radiation, allowing even small abnormalities to be detected and monitored.5
How does MRI work?
Unlike X-rays, MRI does not use ionising radiation. Instead, it relies on radio waves and magnets to create detailed images of the brain.5 See the diagram below for a more detailed explanation.

How MRI Works. Diagram created in BioRender.com
MRI images come in two types:6
- T1 - where empty space appears black and brain tissue is grey/white
- T2 - where the empty space is white and the brain tissue is darker.
A doctor will choose whether to request a T1 or T2 MRI based on the condition being investigated.
What can an MRI show?
A brain MRI scan can detect abnormalities like tumours, inflammation, stroke and other brain injuries.7 Additionally, MRI scans taken at multiple points in time can help doctors identify changes in the brain over time.5 We will explore some of the brain changes often seen on MRI scans of CFD patients below.
MRI findings in cerebral folate deficiency (CFD)
Some of the most common MRI findings in patients with CFD include:
- Brain atrophy3
- White matter changes8
- Enlarged ventricles or extra fluid around the brain9
- Calcifications8
Let’s look at each of these in more detail.
Brain atrophy
Brain atrophy refers to the wasting away of the brain. It can affect the entire brain or just specific parts.
The extent of brain atrophy is linked to the severity of folate deficiency.10 A lack of folate can damage DNA and cause a buildup of harmful chemicals,11 causing brain cells to die, leading to brain atrophy.
In CFD patients as young as 18 months, atrophy has been noted in several brain regions, including the frontal cortex4 (responsible for thinking and speech production), the basal ganglia12 (responsible for motor control), and the cerebellum9 (maintains balance).
What does brain atrophy look like on an MRI image?
On a T1 MRI, there will be more dark areas, as the brain tissue is wasting away, leaving bigger empty spaces than is considered normal.9 These dark regions may be small and dotted across the image (like holes in the brain) or look like larger cavities around the outside of the brain, indicating shrinkage.
How does brain atrophy impact people with CFD?
It depends on which brain regions are affected, but it can cause neurodevelopmental delay or regression, balance issues, or even vision loss.
Enlarged ventricles and extra CSF
The brain floats in a bath of clear fluid called cerebrospinal fluid (CSF). CSF helps to keep the brain clean and protects it against damage. Connected chambers called ventricles allow the CSF to circulate around the brain.13
In CFD, the ventricles can become enlarged (ventriculomegaly). Though the mechanism behind this in humans is not fully understood, research in mice has linked folate deficiency to hydrocephalus – where excessive CSF buildup increases pressure in the ventricles, causing them to swell.14
What does ventriculomegaly look like on an MRI?
On a T1 MRI, the two main ventricles appear as big black areas/ regions in the middle of the brain – this is normal. They resemble butterfly wings from above or look like one big lake from the side.9 However, if they appear wider than approximately 10 mm in a young child,15 this may be a sign of ventriculomegaly.
How does ventriculomegaly impact people with CFD?
Pressure buildup in the brain due to ventriculomegaly can cause a range of complications. In mild cases or very young infants, they may simply appear agitated because they are uncomfortable.3 In more severe cases, it can lead to neurodevelopmental delay or even trigger seizures.16
White matter changes
White matter is made up of nerve fibres which connect brain cells together, allowing them to communicate – like electrical cables. Just like cables are surrounded by a plastic coating, nerve fibres are surrounded by a substance called myelin, which provides insulation and allows signals to be sent along the fibres quickly and efficiently.17
One commonly observed abnormality in the white matter of CFD patients is reduced myelination (hypomyelination) of the nerve fibres8 – think of the plastic coating being stripped from the cables. Folate is crucial for myelin production,18 without which the brain struggles to insulate the nerves, leading to changes in the function and appearance of white matter.
Hypomyelination has been detected using MRI in infants in multiple brain regions, including the area surrounding the ventricles,18 as well as the frontal, parietal, and occipital lobes,19 and the cerebellum.20
What does hypomyelination look like on an MRI?
On a T2 MRI, myelinated areas of the brain appear dark grey. Meanwhile, hypomyelinated areas of the brain appear as brighter, often white spots, making them easy to identify.8 It is important to note that not all bright areas on a scan are abnormal. This is because many parts of the brain are naturally unmyelinated, such as the ventricles. A healthcare professional will be looking for bright spots in brain regions that are usually myelinated, such as brain tissue surrounding the ventricles.19
How does hypomyelination impact people with CFD?
In CFD, hypomyelination can make nerve fibres overactive21, which may lead to symptoms such as seizures. It may also contribute to neurodevelopmental delay or regression, as myelin is needed to develop cognitive and social skills in early life.22
Calcifications
Calcifications are the buildup of excess calcium in the body and have been identified throughout the brains of CFD patients.8 This may be due to a buildup of harmful chemicals triggered by low folate, which can disrupt the balance of calcium levels in the brain.23
What do calcifications look like on an MRI?
Calcifications are hard to spot on conventional T1 or T2 MR images, but a special type of MRI called gradient-echo scans can help visualise them.8 On gradient-echo MRI images, calcifications typically look like dark, wavy lines.
How do calcifications impact people with CFD?
Calcifications have been linked to ataxia, lower limb pyramidal signs, seizures, and speech delay.24
Why MRI matters in CFD diagnosis and monitoring
CFD symptoms overlap with many other conditions, making it difficult to diagnose.4 Using MRI scans can help health professionals to identify key brain changes associated with the disorder. When paired with symptoms and additional tests such as CSF and blood folate levels, this provides a strong, holistic collection of evidence, allowing an informed diagnosis to be made.20 Additionally, MRI may be used to track CFD progression or regression, especially during treatments.25 While feeling better is often the clearest sign that treatment is working, monitoring brain changes can help indicate whether the body is fixing itself as it should.
Summary
Cerebral Folate Deficiency (CFD) is a lack of folate in the brain, primarily affecting infants. It has many symptoms, including neurodevelopmental delay or regression, movement problems and seizures.
Magnetic resonance imaging (MRI) is a non-invasive, low-risk method of scanning the brain that uses magnets and radio waves to produce detailed images.
MRI can reveal key brain changes in CFD patients, including brain atrophy (tissue loss), ventriculomegaly (enlarged ventricles), hypomyelination (loss of protective coating around nerve fibres), and calcifications (calcium deposits). These changes can explain many symptoms of CFD and highlight the crucial role that folate plays in healthy brain development.
Overall, MRI scans help clinicians to spot CFD early and aid them in monitoring the condition to ensure the best possible outcome for the patient.
References
- McFarland R. Cerebral folate deficiency—mishaps and misdirection. Brain [online]. 2012;135(7):2002-3. [5 August 2025]. Available From: https://doi.org/10.1093/brain/aws166
- McGarel C, Pentieva K, Strain JJ, McNulty H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proceedings of the Nutrition Society [online]. 2015;74(1):46-55. [5 August 2025]. Available From: https://doi.org/10.1017/s0029665114001554
- Ramaekers VT, Quadros EV. Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies. Nutrients [online]. 2022;14(15)[5 August 2025]. Available From: https://pmc.ncbi.nlm.nih.gov/articles/PMC9370123/
- Ramaekers V, Sequeira JM, Quadros EV. Clinical recognition and aspects of the cerebral folate deficiency syndromes. Clinical Chemistry and Laboratory Medicine [online]. 2013;51(3):497-511. [5 August 2025]. Available From: https://doi.org/10.1515/cclm-2012-0543
- Thompson PM, Sowell ER, Gogtay N, Giedd JN, Vidal CN, Hayashi KM, et al. Structural MRI and Brain Development. International Review of Neurobiology [online]. 2005;67:285-323. [6 August 2025]. Available From: https://doi.org/10.1016/s0074-7742(05)67009-2
- Symms M, Jäger HR, Schmierer K, Yousry TA. A review of structural magnetic resonance neuroimaging. Journal of Neurology, Neurosurgery & Psychiatry [online]. 2004;75(9):1235. [7 August 2025]. Available From: http://jnnp.bmj.com/content/75/9/1235.abstract
- Aljahdali S, Azim G, Zabani W, Bafaraj S, Alyami J, Abduljabbar A. Effectiveness of radiology modalities in diagnosing and characterizing brain disorders. Neurosciences (Riyadh) [online]. 2024;29(1):37-43. [6 August 2025]. Available From: https://doi.org/10.17712/nsj.2024.1.20230048
- Nicolai J, van Kempen MJ, Postma AA. Teaching NeuroImages: White matter hypomyelination and progressive calcifications in cerebral folate deficiency. Neurology [online]. 2016;87(1):e4-5. [6 August 2025]. Available From: https://www.neurology.org/doi/10.1212/WNL.0000000000002805
- Almahmoud R, Mekki M, El-Hattab AW. Cerebral folate deficiency: A report of two affected siblings. Molecular Genetics and Metabolism Reports [online]. 2023;35:100975. [6 August 2025]. Available From: https://www.sciencedirect.com/science/article/pii/S2214426923000216
- Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. The American Journal of Clinical Nutrition [online]. 2000;71(4):993-8. Available From: https://www.sciencedirect.com/science/article/pii/S0002916523071083
- Kronenberg G, Harms C, Sobol RW, Cardozo-Pelaez F, Linhart H, Winter B, et al. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci [online]. 2008;28(28):7219-30. [7 August 2025]. Available From: https://doi.org/10.1523/JNEUROSCI.0940-08.2008
- Pérez-Dueñas B, Ormazábal A, Toma C, Torrico B, Cormand B, Serrano M, et al. Cerebral Folate Deficiency Syndromes in Childhood: Clinical, Analytical, and Etiologic Aspects. Archives of Neurology [online]. 2011;68(5):615-21. [7 August 2025]. Available From: https://doi.org/10.1001/archneurol.2011.80
- Wichmann TO, Damkier HH, Pedersen M. A Brief Overview of the Cerebrospinal Fluid System and Its Implications for Brain and Spinal Cord Diseases. Front Hum Neurosci [online]. 2021;15:737217. [8 August 2025]. Available From: https://doi.org/10.3389/fnhum.2021.737217
- Santos C, Pai YJ, Mahmood MR, Leung KY, Savery D, Waddington SN, et al. Impaired folate 1-carbon metabolism causes formate-preventable hydrocephalus in glycine decarboxylase-deficient mice. J Clin Invest [online]. 2020;130(3):1446-52. [8 August 2025]. Available From: https://doi.org/10.1172/jci132360
- Garrett WJ, Kossoff G, Warren PS. Cerebral ventricular size in children: a two-dimensional ultrasonic study. Radiology [online]. 1980;136(3):711-5. [8 August 2025]. Available From: https://doi.org/10.1148/radiology.136.3.7403552
- Duy PQ, Rakic P, Alper SL, Butler WE, Walsh CA, Sestan N, et al. Brain ventricles as windows into brain development and disease. Neuron [online]. 2022;110(1):12-5. Available From: https://www.sciencedirect.com/science/article/pii/S0896627321010175
- Stadelmann C, Timmler S, Barrantes-Freer A, Simons M. Myelin in the Central Nervous System: Structure, Function, and Pathology. Physiological Reviews [online]. 2019;99(3):1381-431. [7 August 2025]. Available From: https://journals.physiology.org/doi/abs/10.1152/physrev.00031.2018
- Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, et al. Folate Receptor Alpha Defect Causes Cerebral Folate Transport Deficiency: A Treatable Neurodegenerative Disorder Associated with Disturbed Myelin Metabolism. The American Journal of Human Genetics [online]. 2009;85(3):354-63. [2025/08/07]. Available From: https://doi.org/10.1016/j.ajhg.2009.08.005
- Wang Q, Yang J, Yu C, Deng Y, Wen Q, Yang H, et al. Case Report: Cerebral folate deficiency caused by FOLR1 variant. Front Pediatr [online]. 2024;12:1434209. [7 August 2025]. Available From: https://doi.org/10.3389/fped.2024.1434209
- Al-Baradie RS, Chaudhary MW. Diagnosis and management of cerebral folate deficiency. A form of folinic acid-responsive seizures. Neurosciences (Riyadh) [online]. 2014;19(4):312-6. [7 August 2025]. Available From: https://pmc.ncbi.nlm.nih.gov/articles/PMC4727671/
- de Curtis M, Garbelli R, Uva L. A hypothesis for the role of axon demyelination in seizure generation. Epilepsia [online]. 2021;62(3):583-95. [7 August 2025]. Available From: https://doi.org/10.1111/epi.16824
- Khelfaoui H, Ibaceta-Gonzalez C, Angulo MC. Functional myelin in cognition and neurodevelopmental disorders. Cellular and Molecular Life Sciences [online]. 2024;81(1):181. [7 August 2025]. Available From: https://doi.org/10.1007/s00018-024-05222-2
- Tjiattas L, Ortiz DO, Dhivant S, Mitton K, Rogers E, Shea TB. Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation. Aging Cell [online]. 2004;3(2):71-6. [2025/08/08]. Available From: https://doi.org/10.1111/j.1474-9728.2004.00086.x
- Monfrini E, Arienti F, Rinchetti P, Lotti F, Riboldi GM. Brain Calcifications: Genetic, Molecular, and Clinical Aspects. Int J Mol Sci [online]. 2023;24(10)[8 August 2025]. Available From: https://doi.org/10.3390/ijms24108995
- Dreha-Kulaczewski S, Sahoo P, Preusse M, Gkalimani I, Dechent P, Helms G, et al. Folate receptor α deficiency - Myelin-sensitive MRI as a reliable biomarker to monitor the efficacy and long-term outcome of a new therapeutic approach. J Inherit Metab Dis [online]. 2024;47(2):387-403. [8 August 2025]. Available From: https://doi.org/10.1002/jimd.12713

